FindTrial
Sign In

Tapping into thinking through mobile apps in schizophrenia

Scalable Digital Phenotyping for Momentary Cognition in Early Psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056708
Enrollment
102
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

None listed

Sponsors

Beth Israel Deaconess Medical Center (BIDMC)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosis of a psychotic disorder 2.Severity of symptoms at least to a mild degree on The Positive and Negative Syndrome Scale (PANSS) over the past 3 months 3.If prescribed, a stable medication dosage for at least the past month (self-report and clinical records)

Exclusion criteria

Exclusion criteria: 1.Substance use disorder during the last 3 months 2.Benzodiazepines in the last 4 weeks

Design outcomes

Primary

MeasureTime frame
To assess changes in micro cognitive & contextual momentary performance metrics as correlated to changes in functioning, positive symptoms of schizophrenia, and any changes in the MATRICS Consensus Cognitive Battery (MCCB)Timepoint: 0,90,and180days—

Secondary

MeasureTime frame
To assess changes in micro cognitive & contextual momentary performance in relation to functioning and psychotic-like experiencesTimepoint: 0,90,and180days—

Countries

India, United States of America

Contacts

Public ContactUrvakhsh M Mehta

National Institute of Mental Health and Neuro Sciences

urvakhsh@nimhans.ac.in08026995805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026